MJFF Funding Work Into Role of Autoantibodies in Parkinson’s
The Michael J. Fox Foundation (MJFF) has awarded a grant to Sengenics for work in identifying new autoantibody signatures in people at high risk of Parkinson’s disease, and to investigate these proteins’ role in the disease’s course. “We are delighted to have been awarded this prestigious Michael J. Fox Foundation research…